SAUG-2

N/A

Report date: 2025/02/18 10:49:56

Base Information

Drug NameSAUG-2
Drug Alias NameSAUG-2
ClassificationCell and gene therapy > Gene therapy > LNP
Mechanisms of ActionImmunologic cytotoxicityProgrammed cell death protein 1 blockersT lymphocytes stimulants +[4] 
TargetsCytotoxic T-Lymphocyte-Associated Antigen 4Programmed cell death protein 1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPortage Biotech IncSaugatuck Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSaugatuck Therapeutics LtdPortage Biotech Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A